Skip to main content

Peer Review reports

From: Identification and validation of targets of swertiamarin on idiopathic pulmonary fibrosis through bioinformatics and molecular docking-based approach

Original Submission
20 Jun 2023 Submitted Original manuscript
6 Jul 2023 Reviewed Reviewer Report
10 Jul 2023 Reviewed Reviewer Report - Han Jun
10 Jul 2023 Reviewed Reviewer Report
13 Jul 2023 Reviewed Reviewer Report
19 Jul 2023 Reviewed Reviewer Report
10 Aug 2023 Author responded Author comments - Jun Chang
13 Aug 2023 Author responded Author comments - Jun Chang
Resubmission - Version 2
10 Aug 2023 Submitted Manuscript version 2
18 Aug 2023 Author responded Author comments - Jun Chang
Resubmission - Version 3
18 Aug 2023 Submitted Manuscript version 3
20 Aug 2023 Author responded Author comments - Jun Chang
Resubmission - Version 4
20 Aug 2023 Submitted Manuscript version 4
23 Aug 2023 Author responded Author comments - Jun Chang
Resubmission - Version 5
23 Aug 2023 Submitted Manuscript version 5
25 Aug 2023 Reviewed Reviewer Report
29 Aug 2023 Reviewed Reviewer Report
30 Aug 2023 Reviewed Reviewer Report
3 Sep 2023 Reviewed Reviewer Report - Han Jun
12 Sep 2023 Author responded Author comments - Jun Chang
Resubmission - Version 6
12 Sep 2023 Submitted Manuscript version 6
13 Sep 2023 Author responded Author comments - Jun Chang
Resubmission - Version 7
13 Sep 2023 Submitted Manuscript version 7
Publishing
15 Sep 2023 Editorially accepted
5 Oct 2023 Article published 10.1186/s12906-023-04171-w

You can find further information about peer review here.

Back to article page